Clinical trial
The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor…
NCT00418860 · Samsung Medical Center, Other · Completed
Key facts
| NCT number | NCT00418860 |
|---|---|
| Title | The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent |
| Official title | The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent in the Patients With Coronary Artery Disease (DATE Registry) |
| Acronym | DATE |
| Lead sponsor | Samsung Medical Center, Other |
| Collaborators | Medtronic Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | Aspirin, Clopidogrel |
| Enrollment | 1,200 |
| Start date | Sep 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2009 |
| First posted | Jan 5, 2007 |
| Last update posted | Aug 11, 2011 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: